Cargando…

Curcumin inhibits the growth of triple‐negative breast cancer cells by silencing EZH2 and restoring DLC1 expression

Enhancer of zeste homolog 2 (EZH2), an oncogene, is a commonly up‐regulated epigenetic factor in human cancer. Hepatocellular carcinoma deletion gene 1 (DLC1) is an antioncogene that is either expressed at low levels or not expressed in many malignant tumours. Curcumin is a promising anticancer drug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Xueliang, Jiao, Dechao, Dou, Mengmeng, Zhang, Weijie, Lv, Liying, Chen, Jianjian, Li, Lifeng, Wang, Liuxing, Han, Xinwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521266/ https://www.ncbi.nlm.nih.gov/pubmed/32725802 http://dx.doi.org/10.1111/jcmm.15683

Ejemplares similares

Association of APC gene promoter methylation and the risk of gastric cancer: A meta-analysis and bioinformatics study
por: Zhou, Xueliang, et al.
Publicado: (2020)

Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma
por: Zhou, Xueliang, et al.
Publicado: (2021)

Brachytherapy Combined With or Without Hormone Therapy for Localized Prostate Cancer: A Meta-Analysis and Systematic Review
por: Zhou, Xueliang, et al.
Publicado: (2020)

Elemene injection combined with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A meta-analysis
por: Yao, Yuan, et al.
Publicado: (2019)

Inhibition of cytoplasmic EZH2 induces antitumor activity through stabilization of the DLC1 tumor suppressor protein
por: Tripathi, Brajendra K., et al.
Publicado: (2021)

Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells
por: Thulasiraman, Padmamalini, et al.
Publicado: (2014)

Novel miRNA Predicts Survival and Prognosis of Cholangiocarcinoma Based on RNA-seq Data and In Vitro Experiments
por: Yao, Yuan, et al.
Publicado: (2020)

The oncogenic miR-429 promotes triple-negative breast cancer progression by degrading DLC1
por: Li, Yao, et al.
Publicado: (2023)

CELF2 is a candidate prognostic and immunotherapy biomarker in triple‐negative breast cancer and lung squamous cell carcinoma: A pan‐cancer analysis
por: Wang, Libo, et al.
Publicado: (2021)

DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers
por: Wang, Dunrui, et al.
Publicado: (2016)

Development and validation of a robust immune-related risk signature for hepatocellular carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Survival and clinical success of endovascular intervention in patients with Budd-Chiari syndrome: A systematic review
por: Mukhiya, Gauri, et al.
Publicado: (2023)

Percutaneous transhepatic intraluminal forceps biopsy for patients with biliary stricture after endoscopic retrograde approach failure: a retrospective study
por: Liu, Yiming, et al.
Publicado: (2023)

TACE sequential MWA guided by cone-beam computed tomography in the treatment of small hepatocellular carcinoma under the hepatic dome
por: Li, Zhaonan, et al.
Publicado: (2023)

LINC00114 stimulates growth and glycolysis of esophageal cancer cells by recruiting EZH2 to enhance H3K27me3 of DLC1
por: Qin, Jianzhang, et al.
Publicado: (2022)

CDK5 opens the way for DLC1
por: Short, Ben
Publicado: (2014)

Surface Reformation of Medical Devices with DLC Coating
por: Kaneko, Mao, et al.
Publicado: (2021)

Document Liveness Challenge Dataset (DLC-2021)
por: Polevoy, Dmitry V., et al.
Publicado: (2022)

Functional analysis of the Drosophila RhoGAP Cv-c protein and its equivalence to the human DLC3 and DLC1 proteins
por: Sotillos, Sol, et al.
Publicado: (2018)

Silence of α1-Antitrypsin Inhibits Migration and Proliferation of Triple Negative Breast Cancer Cells
por: Zhao, Zhijing, et al.
Publicado: (2018)

Analysis of EZH2 Genetic Variants on Triple-Negative Breast Cancer Susceptibility and Pathology
por: Liu, Liang-Chih, et al.
Publicado: (2022)

Properties of titanium-alloyed DLC layers for medical applications
por: Joska, Ludek, et al.
Publicado: (2014)

Multifractal investigation of Ag/DLC nanocomposite thin films
por: Ţălu, Ştefan, et al.
Publicado: (2020)

The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1
por: Liao, Yi-Chun, et al.
Publicado: (2007)

Author Correction: Functional analysis of the Drosophila RhoGAP Cv-c protein and its equivalence to the human DLC3 and DLC1 proteins
por: Sotillos, Sol, et al.
Publicado: (2020)

Roles of Bile-Derived Exosomes in Hepatobiliary Disease
por: Yao, Yuan, et al.
Publicado: (2021)

Evaluation of outcome from endovascular therapy for Budd-Chiari syndrome: a systematic review and meta-analysis
por: Mukhiya, Gauri, et al.
Publicado: (2022)

Safety and efficacy of iodine-125 seed strand for intraluminal brachytherapy on ureteral carcinoma
por: Bi, Yonghua, et al.
Publicado: (2023)

Non-Canonical EZH2 Transcriptionally Activates RelB in Triple Negative Breast Cancer
por: Lawrence, Cortney L., et al.
Publicado: (2016)

Significance of genetic variants in DLC1 and their association with hepatocellular carcinoma
por: XIE, CHENG-RONG, et al.
Publicado: (2015)

DLC1: a tumor suppressor that regulates Rho signaling
por: Tripathi, Brajendra K., et al.
Publicado: (2017)

Synthesis of Multilayered DLC Films with Wear Resistance and Antiseizure Properties
por: Li, Yucheng, et al.
Publicado: (2021)

Improving frictional properties of DLC films by surface energy manipulation
por: Wang, Jia, et al.
Publicado: (2018)

Laser Structuring and DLC Coating of Elastomers for High Performance Applications
por: Vogel, Sönke, et al.
Publicado: (2022)

Endothelial DLC1 is dispensable for liver and kidney function in mice
por: Tan, Ying, et al.
Publicado: (2020)

Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial–mesenchymal transition in triple‐negative breast cancer
por: Lv, Zhi‐Dong, et al.
Publicado: (2016)

DLC1 Is a Prognosis-Related Biomarker Correlated With Tumor Microenvironment Remodeling in Endometrial Carcinoma
por: Wu, Yalan, et al.
Publicado: (2022)

Inhibition of EZH2 prevents fibrosis and restores normal angiogenesis in scleroderma
por: Tsou, Pei-Suen, et al.
Publicado: (2019)

EZH2 inhibitors-mediated epigenetic reactivation of FOSB inhibits triple-negative breast cancer progress
por: Zhang, Ruishan, et al.
Publicado: (2020)

Capsanthin induces G1/S phase arrest, erlotinib-sensitivity and inhibits tumor progression by suppressing EZH2-mediated epigenetically silencing of p21 in triple-negative breast cancer cells
por: Wu, Jia-Yan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p7th9uij0cmqlhuovb1n7vhlgq